Skip to main content
Current Drug Therapy publishes frontier reviews on all the latest advances in drug therapy. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: new and existing drugs, therapies and medical devices.

The journal is essential reading for all researchers and clinicians involved in drug therapy.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 1, 2019

Articles

Free Content Graphical Abstracts
pp. i-iv(4)

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 1-1(1)
Author: Theodorakis, Emmanuel A.

Favourites:
ADD

Preface

Free Content Preface
pp. 2-2(1)
Author: Palomba, Stefano

Favourites:
ADD

Review article

Biomimetic Approaches for Targeted Nanomedicine: Current Status and Future Perspectives
pp. 3-15(13)
Authors: Agnihotri, Jaya; Maurya, Priyanka; Singh, Shobhna; Saraf, Shubhini A.

Favourites:
ADD

Bio-analytical Assay Methods used in Therapeutic Drug Monitoring of Antiretroviral Drugs-A Review
pp. 16-57(42)
Authors: Charbe, Nitin B.; Zacconi, Flavia C.; Amnerkar, Nikhil; Ramesh, B.; Tambuwala, Murtaza M.; Clementi, Emilio

Favourites:
ADD

Research article

Effect of Myricetin on the Loss of Dopaminergic Neurons in the Transgenic Drosophila Model of Parkinson’s Disease
pp. 58-64(7)
Authors: Ara, Gulshan; Afzal, Mohammad; Jyoti, Smita; Naz, Falaq; Rahul; Siddique, Yasir H.

Favourites:
ADD

Preparation and Characterization of Freeze-dried Liposomes Loaded with Amphotericin B
pp. 65-73(9)
Authors: Yen, Tran T. H.; Nho Dan, Le; Duc, Le H.; Tung, Bui Thanh; Hue, Pham Thi Minh

Favourites:
ADD

Comparison of Valvulopathy Risk with Lorcaserin and Phenterminetopiramate for Weight Loss
pp. 74-78(5)
Authors: Guo, Michael; Etminan, Mahyar; Carleton, Bruce

Favourites:
ADD

An in silico Approach to Identify Potential NDM-1 Inhibitors to Fight Multidrug Resistant Superbugs
pp. 79-84(6)
Authors: Barman, Seema; Phukan, Bonashree; Borah, Partha S.; Puzari, Minakshi; Sharma, Mohan; Chetia, Pankaj

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content